BIOREM Inc.
BRM.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 46.66% | 67.53% | 18.97% | -1.12% | -15.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.66% | 67.53% | 18.97% | -1.12% | -15.43% |
| Cost of Revenue | 48.55% | 56.91% | 17.11% | -4.16% | -12.62% |
| Gross Profit | 41.78% | 95.81% | 23.48% | 6.36% | -21.93% |
| SG&A Expenses | 41.90% | 11.65% | -20.34% | -28.63% | -34.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -3,200.00% | -- | -- | -- |
| Total Operating Expenses | 47.17% | 46.80% | 8.31% | -9.85% | -17.65% |
| Operating Income | 43.04% | 388.58% | 152.85% | 102.46% | 4.79% |
| Income Before Tax | 48.12% | 545.93% | 217.50% | 120.38% | 14.69% |
| Income Tax Expenses | 78.86% | 298.31% | 106.65% | 49.11% | -21.72% |
| Earnings from Continuing Operations | 39.44% | 710.35% | 280.80% | 157.71% | 32.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.44% | 710.35% | 280.80% | 157.71% | 32.04% |
| EBIT | 43.04% | 388.58% | 152.85% | 102.46% | 4.79% |
| EBITDA | 46.75% | 345.47% | 129.18% | 83.47% | 0.06% |
| EPS Basic | 39.51% | 691.83% | 271.33% | 151.92% | 29.63% |
| Normalized Basic EPS | 48.22% | 531.45% | 209.43% | 115.05% | 12.45% |
| EPS Diluted | 10.97% | 730.43% | 334.52% | 178.70% | 30.40% |
| Normalized Diluted EPS | 40.87% | 716.06% | 272.12% | 148.27% | 20.13% |
| Average Basic Shares Outstanding | 0.00% | 0.66% | 0.82% | 1.18% | 1.54% |
| Average Diluted Shares Outstanding | 7.84% | 5.43% | 4.70% | -1.65% | -4.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |